Company Market Research Report: ATCC

Company Overview

• Name: ATCC (American Type Culture Collection)

• Mission: ATCC is committed to providing researchers with credible, cutting-edge models to enable breakthroughs in diagnostics development, drug discovery, and translational research.

• Founded: No information is available regarding the founding date and by whom.

• Key People: No specific key people mentioned.

• Headquarters: Manassas, Virginia, USA.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: ATCC is a nonprofit, global biological resource center and standards organization, recognized as a leading developer and supplier of authenticated cell lines and microorganisms.

Products and Services

Cell Products

• Assay Ready Cells: Cells that transition from a frozen state to ready-to-use data in one day.

• HCMI Cancer Models: Advanced biological models and patient-derived cell lines for cancer research.

• DHFR-deficient CHO Derivative Cell Lines: Newly offered CHO derivative cells lines that are dihydrofolate reductase (DHFR)-deficient, used for specific scientific studies.

Microbe Products

• MicroQuant™: Controls for microbial QC testing, offering precise quantitation and rapid rehydration.

• Genomic RNA from SARS-CoV-2 Omicron BA.5: Offers quantitative genomic RNA for assay development and validation.

Services

• Standards and Controls: High-quality reference materials and national consensus standards.

• Deposit Services: Options include general collection, patent deposit, National Park Service deposit, and type strain deposit.

Federal Solutions

• Provision of specialized biomanufacturing and biomaterial management services in adherence to governmental requirements.

Key Features

• Quality Assurance: ATCC is ISO 9001, ISO 13485, ISO/IEC 17025, and ISO 17034 certified, ensuring high product standards.

• Research Support: Supplies materials essential for research in antimicrobial resistance, infectious diseases, cancer, and more.

Recent Developments

• New Biomanufacturing Suite: ATCC received a C06 Research Facilities Construction Grant from ORIP (NIH) to build a new biomanufacturing suite at its Manassas headquarters.

• NIAID Contract: Awarded an IDIQ contract by NIAID to support infectious disease treatment and research.

• COF Grant: ATCC received a COF grant from the Virginia Economic Development Partnership for its new biomanufacturing suite.

New Products

• EPA Seed Sanitizer Panel: Developed with the FDA and EPA collaboration for industry efficacy data.

• Immortalized Preadipocytes: Both brown and white preadipocytes for studies in obesity and toxicity.

Partnerships and Collaborations

• Synthego Alliance: Alliance for gene editing of mammalian and mouse cell lines.

• Tissue Dynamics Collaboration: United for groundbreaking drug testing technology, including bringing a transformative heart organoid model to market.

Conclusion

ATCC strives to provide high-quality biological resources and standards, demonstrated through its wide array of products, certifications, and global partnerships. Its commitment to advancing scientific research and public health is evident in the company's strategic developments, innovative products, and sustained focus on quality and compliance.